Boston Scientific Corporation/ US1011371077 /
| 2024-04-26 10:10:00 PM | Chg. -0.09 | Volume | Bid2:00:00 AM | Ask2:00:00 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 73.17USD | -0.12% | 8.79 mill. Turnover: 537.97 mill. |
72.50Bid Size: 100 | 74.18Ask Size: 100 | 107.35 bill.USD | - | 67.75 |
Assets
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 1,697 | 1,670 | 1,564 | 1,546 | 1,507 | ||||||
| Intangible Assets | 6,343 | 6,473 | 6,289 | 5,950 | 5,606 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | - | - | - | - | 13,436 | ||||||
| Inventories | 894 | 931 | 884 | 897 | 946 | ||||||
| Accounts Receivable | - | - | - | - | 1,183 | ||||||
| Cash and Cash Equivalents | 213 | 267 | 207 | 217 | 587 | ||||||
| Current Assets | 3,615 | 3,105 | 3,022 | 3,011 | 3,606 | ||||||
| Total Assets | 22,128 | 21,290 | 17,154 | 16,571 | 17,042 | ||||||
Liabilities
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 184 | 203 | 232 | 246 | 262 | ||||||
| Long-term debt | - | - | - | - | 3,859 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 1,644 | 1,865 | 1,729 | 1,402 | 1,214 | ||||||
| Liabilities | 10,832 | 9,937 | 10,284 | 10,032 | 10,585 | ||||||
| Share Capital | - | - | - | - | 16 | ||||||
| Total Equity | 11,296 | 11,353 | 6,870 | 6,539 | 6,457 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 22,128 | 21,290 | 17,154 | 16,571 | 17,042 | ||||||
Income Statement
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 7,806 | 7,622 | 7,249 | 7,143 | 7,380 | ||||||
| Depreciation (total) | 513 | 421 | 395 | 410 | 438 | ||||||
| Operating Result | -656 | 904 | -3,868 | 120 | -301 | ||||||
| Interest Income | -393 | -281 | -261 | -324 | -216 | ||||||
| Income Before Taxes | -1,063 | 642 | -4,107 | -223 | -509 | ||||||
| Income Taxes | 2 | 201 | -39 | -102 | -390 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | -1,065 | 441 | -4,068 | -121 | -119 | ||||||
Per Share
Cash Flow
|
2010 US GAAP in mill. USD |
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 325 | 1,008 | 1,260 | 1,082 | 1,269 | ||||||
| Cash Flow from Investing Activities | -480 | 769 | -579 | -475 | -745 | ||||||
| Cash Flow from Financing | -496 | -1,721 | -744 | -596 | -150 | ||||||
| Decrease / Increase in Cash | -651 | 54 | -60 | 10 | 370 | ||||||
| Employees | 25,000 | 24,000 | 24,000 | 23,000 | 24,000 | ||||||
